CAS 70059-30-2
:Cimetidinhydrochlorid
- 1-cyano-2-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine hydrochloride (1:1)
- 3-Cyano-2-methyl-1-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine hydrochloride
- Aciloc
- Biomag
- Brumetidina
- Cimetex
- Cimetidine HCL
- Guanidine, N-cyano-N′-methyl-N′′-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]-, hydrochloride (1:1)
- Guanidine, N-cyano-N′-methyl-N′′-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]-, monohydrochloride
- Notul
- Tagamet Injection
- Tagamet Liquid
- Weitere Synonyme anzeigen
CIMETIDINE HYDROCHLORIDE CRS
CAS:CIMETIDINE HYDROCHLORIDE CRSFormel:C10H17ClN6SFarbe und Form:Crystalline Powder. White. Powder.Molekulargewicht:288.8002Cimetidine Hydrochloride
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormel:C10H16N6S·ClHFarbe und Form:White Off-White PowderMolekulargewicht:288.09239Cimetidine hydrochloride
CAS:Cimetidine (SKF-92334) is an oral H2 blocker with Ki 0.6 μM, anti-cancer and anti-inflammatory properties, used for ulcer research.Formel:C10H17ClN6SFarbe und Form:SolidMolekulargewicht:288.8Cimetidine hydrochloride
CAS:Cimetidine is a histamine-2 receptor antagonist that is used to treat peptic ulcers and gastric acid hypersecretion. It has been shown to reduce the growth of tumor cells in culture and to inhibit the synthesis of interferon alfa-2b, polymerase chain reaction (PCR) products, and carbenoxolone sodium. Cimetidine has also been shown to have a long-term toxicity in rats and mice. These effects are believed to be due to cimetidine's inhibition of plasma mass spectrometry and its ability to induce metabolic disorders such as hypokalemia, hypomagnesaemia, hypercholesterolemia, hyperglycemia, or hypothyroidism. The drug may also cause anaphylactic reactions or allergic reactions such as urticaria or angioedema. Cimetidine is not intended for injection because it is unstable when mixed with water. Famotidine is a prodrug that is
Reinheit:Min. 95%




